Does CABAZITAXEL Cause Transient ischaemic attack? 5 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Transient ischaemic attack have been filed in association with CABAZITAXEL (Jevtana). This represents 0.2% of all adverse event reports for CABAZITAXEL.
5
Reports of Transient ischaemic attack with CABAZITAXEL
0.2%
of all CABAZITAXEL reports
2
Deaths
4
Hospitalizations
How Dangerous Is Transient ischaemic attack From CABAZITAXEL?
Of the 5 reports, 2 (40.0%) resulted in death, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABAZITAXEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which CABAZITAXEL Alternatives Have Lower Transient ischaemic attack Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE